Alexandria plans sprawling R&D complex in India

Alexandria Real Estate is best known in biotech circles for its U.S. developments. But an Indian newspaper says that the developer is laying out plans for a sprawling R&D complex and life science incubator on 25 acres next to Tata Motors' Nano project in Sanand.

"After putting up the facility, it will go in for marketing its space. It will surely attract top biotech players," a government official told the Economic Times. "Alexandria has agreed to put up its facility on the condition of zero discharge of effluents. This is particularly important, as the area near Nano (a low-cost minicar) does not have any effluent disposal pipelines."

Alexandria has built a number of life sciences developments around the U.S. It's also invested in U.S. biotech companies.

- read the story in the Economic Times

Suggested Articles

Insitro picked up $143 million to build out its technology, pursue new targets and advance treatments for genetically defined patient groups.

Generation Bio filed for a $215 million IPO to advance a pair of gene therapies for liver disease and push one of them into the clinic.

The IPO will push Avidity's lead muscle disorder program through IND-enabling studies and into the clinic in 2021.